Innovative Cellular Therapeutics Holdings Ltd, 10% Owner at Lyell Immunopharma, Inc. (LYEL), sold 10 shares at $13.70 ($137) on 2026-07-17, disclosed to the SEC on 2026-07-20.
Open-market sale of $137 LYEL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.